The Flu Vaccine Market is witnessing consistent and robust expansion, poised for steady growth in the coming years. By 2024, it is projected to reach a valuation of approximately US$ 5,831.7 million. Expectations suggest a compounded annual growth rate (CAGR) of 6.7% from 2024 to 2034, propelling the market to exceed US$ 11,181.3 million by the end of 2034.
The flu vaccine industry...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)